Medicines Australia says maintains its longstanding concern over the conditional nature of PBAC recommendations and that it could be considered in the upcoming health technology assessment review.
MA: HTA review could consider new non-PBAC pricing body
January 20, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Anteris Technologies expands its medical advisory board
May 25, 2022 - - Australian Biotech -
Archer Materials secures Australian patent for quantum computing chip
May 25, 2022 - - Australian Biotech -
New clinical trial to test cancer drug in motor neuron disease
May 25, 2022 - - Latest News -
Australian Dental Association anticipates change in aged care
May 25, 2022 - - Other Health -
New plan to build a disability confident culture at Medibank
May 25, 2022 - - Other Health -
Bupa giving customers greater transparency and choice
May 25, 2022 - - Other Health -
US-based industry sets objectives for new trade alliance
May 25, 2022 - - Latest News